High Ground Investment Management LLP Trims Position in Humana Inc. $HUM

Key Points

• High Ground trimmed its stake: High Ground Investment Management reduced its Humana holding by 2.0% to 493,963 shares (about $126.5M), making HUM the firm’s third-largest position at 18.4% of its portfolio.
• Quarterly results and guidance: Humana reported Q earnings of −$3.96 per share (beating estimates) on $32.64B revenue (+11.3% y/y) and set FY2026 guidance at $9.00 EPS.
• Investor and analyst signals: The company declared a $0.885 quarterly dividend (1.8% yield) and an insider purchased 810 shares, while analyst coverage remains mixed with an average "Hold" rating and a $223.78 average price target.

High Ground Investment Management LLP trimmed its position in shares of Humana Inc. (NYSE:HUM - Free Report) by 2.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 493,963 shares of the insurance provider's stock after selling 9,838 shares during the quarter. Humana accounts for 18.4% of High Ground Investment Management LLP's portfolio, making the stock its 3rd largest position. High Ground Investment Management LLP owned approximately 0.41% of Humana worth $126,519,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. CoreCap Advisors LLC boosted its position in shares of Humana by 54.4% during the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider's stock worth $27,000 after purchasing an additional 37 shares in the last quarter. Rosenberg Matthew Hamilton raised its holdings in shares of Humana by 136.0% during the fourth quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider's stock worth $30,000 after acquiring an additional 68 shares during the period. Mather Group LLC. acquired a new stake in shares of Humana during the third quarter worth $34,000. Private Wealth Management Group LLC raised its holdings in shares of Humana by 47.5% during the third quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider's stock worth $39,000 after acquiring an additional 48 shares during the period. Finally, Larson Financial Group LLC raised its holdings in shares of Humana by 114.1% during the third quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider's stock worth $40,000 after acquiring an additional 81 shares during the period. 92.38% of the stock is owned by institutional investors.

Humana Stock Down 0.1%

Shares of HUM stock opened at $192.01 on Monday. The company has a current ratio of 2.00, a quick ratio of 2.00 and a debt-to-equity ratio of 0.70. Humana Inc. has a 1 year low of $163.11 and a 1 year high of $315.35. The firm's fifty day moving average price is $180.55 and its two-hundred day moving average price is $232.58. The firm has a market capitalization of $23.05 billion, a P/E ratio of 19.55, a PEG ratio of 2.06 and a beta of 0.44.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share (EPS) for the quarter, beating the consensus estimate of ($4.01) by $0.05. Humana had a net margin of 0.92% and a return on equity of 11.43%. The firm had revenue of $32.64 billion for the quarter, compared to analyst estimates of $32.08 billion. During the same period in the previous year, the business earned ($2.16) EPS. The company's revenue was up 11.3% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. On average, equities analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Friday, March 27th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.8%. The ex-dividend date is Friday, March 27th. Humana's payout ratio is presently 36.05%.

Insider Transactions at Humana

In other Humana news, insider Sanjay K. Shetty purchased 810 shares of the stock in a transaction on Monday, February 23rd. The shares were purchased at an average cost of $185.21 per share, for a total transaction of $150,020.10. Following the purchase, the insider owned 11,657 shares of the company's stock, valued at approximately $2,158,992.97. This represents a 7.47% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.20% of the company's stock.

Humana News Roundup

Here are the key news stories impacting Humana this week:

• Positive Sentiment: Board expanded and Robert S. Field elected to the board — Field is a healthcare-focused investor with managed‑care experience, which investors may view as a strategic governance upgrade. Humana Elects Robert S. Field to Board of Directors
• Positive Sentiment: Bank of America raised its price target to $210 (from $196), signaling improved analyst confidence in Humana’s outlook. Humana price target raised to $210 from $196 at BofA
• Positive Sentiment: Humana is live with b.well and has partnerships (Noom, Welldoc) to expand health-data interoperability — supports member engagement, care coordination and potential cost/care outcomes improvements. Humana Goes Live with b.well
• Positive Sentiment: Value-based pharmacist program in Ohio aims to improve hypertension/diabetes outcomes and reduce costs — a tangible care-management initiative investors favor. Humana Bets on Pharmacists to Lift Chronic Care Outcomes
• Neutral Sentiment: Some analysts and commentaries remain cautious: a recent note argues Humana is still a “hold” despite Medicare Advantage rate tailwinds, tempering upside expectations. Humana Is Still A Hold Despite The Medicare Advantage Rate Boost
• Neutral Sentiment: Unusually large options activity and prior analyst-driven gap-ups indicate elevated trading interest and positioning that can increase intraday volatility. Humana Target of Unusually Large Options Trading
• Neutral Sentiment: Technical note — the stock recently crossed above its 50‑day moving average (a positive sign for some traders), which may be attracting short-term buying. Humana Surges Above 50-Day MA
• Negative Sentiment: Short interest rose ~19.3% in March to 5.94M shares (about 5.0% of shares sold short) with a ~3.5 days-to-cover — higher short exposure can amplify downward pressure and volatility.
• Negative Sentiment: Negative market narratives: a recent piece flagged Humana among “casualties” in the sector, which can weigh on sentiment and prompt selling by momentum or sector-focused funds. Humana and Thor Hit the Casualty List

Analyst Ratings Changes

A number of brokerages recently commented on HUM. Zacks Research upgraded shares of Humana from a "strong sell" rating to a "hold" rating in a report on Thursday, March 5th. Sanford C. Bernstein restated an "outperform" rating and set a $344.00 price objective on shares of Humana in a report on Tuesday, January 6th. Truist Financial dropped their price objective on shares of Humana from $285.00 to $200.00 and set a "hold" rating on the stock in a report on Tuesday, February 17th. Deutsche Bank Aktiengesellschaft set a $180.00 price objective on shares of Humana and gave the stock a "hold" rating in a report on Friday, February 13th. Finally, TD Cowen dropped their price objective on shares of Humana from $260.00 to $173.00 and set a "hold" rating on the stock in a report on Friday, February 13th. Seven equities research analysts have rated the stock with a Buy rating, sixteen have assigned a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and an average price target of $223.78.

Humana Profile

Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.